HR 174

Louisiana House bill in Session 2026R.

Status: in_committee. Latest action: May 18, 2026.

DRUGS/TESTING: Requests the state surgeon general and the Louisiana Department of Health to assess the feasibility of advancing fenbendazole for potential human use in cancer treatment and to provide guidance on engaging federal authorities for expedited evaluation while protecting public health.

Bill ID LA-2026R-HR-174

Session 2026R

Status in_committee

Committee final passage - Sched. for 5/18/26

House in_committee 2026-05-18

Sponsor

Charles Owen

Official Source Back to Bills

Actions Timeline

Date	Event	Detail
2026-04-20	Introduced	Bill introduced
2026-05-18	Status	in_committee
2026-05-18	Latest Action	Scheduled for floor debate on 05/18/2026.

More Bills From This Sponsor

HR 286

RURAL/DEVELOPMENT: Urges and requests Louisiana Economic Development to study the feasibility of a Louisiana Rural Community Energy and Education Investment Program

in_committee • House

HB 288

HEALTH CARE/RECORDS: Provides for the use of certain medical terminology in medical documentation (EG NO IMPACT See Note)

in_committee • House

HCR 11

MILITARY AFFAIRS: Expresses support for the continued operations of the Louisiana National Guard at Camp Beauregard in Pineville and commends the accomplishments of the Louisiana National Guard Youth Challenge Program

unknown • House

HB 321

HUMAN TRAFFICKING: Provides relative to victims of human trafficking and prostitution offenses (EG NO IMPACT See Note)

passed_lower • House

HB 578

CIVIL/LAW: Provides for the Restoring Biological Truth Act

passed_lower • House

HB 609

HEALTH CARE/RECORDS: Provides for the exemption of fees for health records when requested for the federal and state veterans affairs departments

in_committee • House